On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
The Ted Rogers Centre and its partners are committed to helping commercialize new cardiovascular innovations and technologies so they may reach the market sooner.
The ECHO program is a key part of that mission – and is open to any Canadian-based clinician, scientist, entrepreneur and/or student. Applications for the 2020-21 year closed on August 28th.
Canada-wide for 2020-21
To reach teams across Canada, ECHO is now entirely virtual, beginning in 2020. We are pleased to announce a call for applications for the 2020-2021 ECHO program.
Founded in 2018, ECHO is a 12-month online training program led by veteran entrepreneurs and high-calibre consultants across a variety of sectors. Comprised of a unique combination of five complementary modules, ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, and networking opportunities, and the chance to pitch for start-up funding from a $250,000 pool.
Please visit our ECHO website for more details.
ECHO is organized and funded by the Translational Biology and Engineering Program (TBEP) – the University of Toronto component of the Ted Rogers Centre for Heart Research – in partnership with the Health Innovation Hub (H2i), a University of Toronto campus-linked accelerator.